In part 2 of this series, we continue the conversation with Dr. Daniel Emina about the use of SPECT brain scans in studying blood flow patterns that correlate with symptom clusters. Listen in as we dive a little deeper and talk about the process used to analyze data from SPECT scans to help create treatment plans for patients experiencing mental illness symptoms.
Listen to Episode
In today’s episode, we have the timely opportunity to discuss Colorado Proposition 122 with one of its co-authors, attorney Josh Kappel. The Natural Medicine Health Act of Colorado would create a pathway to legalize psilocybin therapy in Colorado, and contains some very interesting nuances that make this initiative revolutionary and distinct from other state initiatives. We’ll talk about what this means for therapists, practitioners, and other facilitators. Join us as we dig into the details with drug policy reform advocate and founding partner of Vicente Sederberg law firm, Josh Kappel.
Listen to Episode
In this episode, we sit down with Dr. Daniel Emina, Psychiatrist and Associate Medical Director at Amen Clinics, to discuss SPECT brain scans and the role that this revolutionary technology has in the field of integrative psychiatry. During this two-part series we’ll talk about the advantages of SPECT brain scans and even some of the controversy surrounding this type of imaging.
Listen to Episode
In today’s episode, we discuss the new & exciting developments that are happening in Oregon, surrounding the Ballot Measure 109, which refers to the regulatory licensing and use of psilocybin products and services. Listen in as we go over details of this new Oregon law as we understand it, the risks and advantages of psilocybin as a therapeutic model, and a somewhat similar initiative that will be on Colorado’s ballot this coming November.
Listen to Episode
In today’s episode, we’re joined by renowned speaker and bestselling author, Dr. Gabor Maté, to discuss his latest book entitled “The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture”. Listen in as we discuss some of the highlights of the book, including the causes of illness, the effect that toxic culture has on our minds and bodies, and a pathway to health and healing.
Listen to Episode
Money and mental health. It’s a topic that isn’t discussed as often as it should be, especially in the practice of psychotherapy.
In today’s episode, we sit down with financial therapist and author of, “The Art of Money”, Bari Tessler to discuss the psychology of money and where many money habits come from. Bari will also share few techniques that you can use to help your clients or patients, and even yourself, create a more mindful and meaningful relationship with money.
Listen to Episode
What exactly is trauma? How many people actually carry trauma in their bodies? How do we know the actual source of our trauma’s when it’s not a specific event that happened? What if the source of one’s trauma is intergenerational—passed down from previous generations?
In today’s episode, we take a deeper look at these difficult questions that need answers in order to heal on the personal and collective level in society.
Listen to Episode
As a society we have become more and more disconnected with nature. This phenomenon and the psychological and physical stress it has placed on many of us is referred to as Nature-Deficit Disorder. It’s a growing problem that was only heightened by the pandemic. Nature can regulate the nervous system in ways that are difficult to attain otherwise. Nature is truly food for the soul.
In today’s episode we’ll dive deep into a discussion on the correlation between nature and mental health, and discuss our personal experiences with nature’s healing power.
Listen to Episode
© 2024 Integrative Psychiatry Institute
Sara Reed, MS, LMFT
Sara Reed is a Licensed Marriage and Family Therapist and CEO of Mind’s iHealth Solutions, a digital health company that provides evidence based and culturally responsible mental health services for underserved groups. As a mental health futurist and clinical researcher, Sara examines the ways culture informs the way we diagnose and treat mental illness. Sara’s prior research work includes participation as a study therapist in psychedelic therapy research at Yale University and the University of Connecticut’s Health Center. Sara was the first Black therapist to provide MDMA-assisted psychotherapy in a clinical trial and continues to engage in ongoing advocacy work around health equity in psychedelic medicine.
Jeffrey Guss, MD is a psychiatrist, psychoanalyst, and researcher with specializations in psychoanalytic therapy and the treatment of substance use disorders. He was Co-Principal Investigator and Director of Psychedelic Therapy Training for the NYU School of Medicine’s study on psychedelic-assisted psychotherapy in the treatment of cancer-related existential distress, which was published in Journal of Psychopharmacology, 2016. He currently is a study therapist in the NYU study on Psychedelic-Assisted therapy in the treatment of Alcoholism, a collaborator with Yale University’s study on psychedelic-assisted therapy for Major Depressive Disorder and a study therapist with the MAPS (Multidisciplinary Association for Psychedelic Studies) study on treatment of Post Traumatic Stress Disorder with Psychedelic-Assisted Psychotherapy.
Dr. Guss is interested in the integration of psychedelic therapies with contemporary psychoanalytic theory and has published in Studies in Gender and Sexuality and Psychoanalysis, Culture and Society. He has published (with Elizabeth Nielson, PhD) a paper on “the influence of therapists’ first had experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training” in The Journal of Psychedelic Studies, August, 2018. He is an Instructor and Mentor with the California Institute of Integral Studies’ Center for Psychedelic Therapies and Supervisor in NYU’s Fellowship in Addiction Psychiatry.
Dr. Guss maintains a private practice in New York City.
Will Van Derveer, MD
Will Van Derveer, MD is Co-Founder of Integrative Psychiatry Institute and Integrative Psychiatry Centers. Dr. Van Derveer was co-investigator on a phase 2 MAPS study of Psychedelic-assisted psychotherapy for treatment-resistant PTSD, and co-authored the publication of this study in 2018. He has also provided Psychedelic-assisted psychotherapy in two MAPS training studies. An active provider of KAP at his clinic in Boulder, CO, he has been teaching others KAP therapy for several years. Dr. Van Derveer contributed a chapter on mescaline in the 2021 "Handbook of Medical Hallucinogens" (edited by Charles Grob and Jim Grigsby). He is co-host of the Higher Practice Podcast.
Dr. Van Derveer regards unresolved emotional trauma as the most significant under-recognized root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.
For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass.
Scott has been a student of consciousness since his honors thesis on that topic at the University of Arizona in the 1970s under the tutelage of Dr. Andrew Weil. Following medical school, Scott studied Jungian therapy and acupuncture while working as a primary care physician in a rural area for four years. Psychedelic-assisted psychotherapy became a facet of his practice before this medicine was scheduled in 1985. He then completed a psychiatry residency at Columbia program in New York. Scott studied cross-cultural psychiatry and completed a child/adolescent psychiatry fellowship at the University of New Mexico.
In 2010 he founded Wholeness Center in Fort Collins. This innovative clinic provides cross-disciplinary evaluation and care for all mental health concerns. Scott serves as a site Principal Investigator and therapist for the Phase III trial of psychedelic-assisted psychotherapy for PTSD sponsored by (MAPS). He has also published numerous articles about his research on (CBD) in mental health. Currently, Scott works extensively with psychedelic-assisted-psychotherapy. He lectures all over the world to professional groups interested in a deeper look at mental health issues, safer tools, and a paradigm-shifting perspective about transformative care.
Will Van Derveer, MD is co-founder of Integrative Psychiatry Institute (IPI), along with friend and colleague Keith Kurlander, MA. He co-created IPI as an expression of what he stands for. First, that anyone can heal, and second that we medical providers must embrace our own healing journeys in order to fully command our potency as healers.
Dr. Van Derveer spent the last 20 years innovating and testing a comprehensive approach to addressing psychiatric challenges which transcends the conventional model he learned in medical school at Vanderbilt University and residency at University of Colorado, while deeply engaging his own healing path.
He founded the Integrative Psychiatric Healing Center in in 2001 in Boulder, CO, where he currently practices. Dr. Van Derveer regards unresolved emotional trauma as the most significant root cause of psychiatric symptoms in integrative psychiatry practice, along with gut issues, hormone imbalances, inflammation, mitochondrial dysfunction, and other functional medicine challenges. He is trained in Somatic Experiencing, EMDR, Internal Family Systems, and other psychotherapy techniques. His current clinical passion is psychedelic-assisted psychotherapy, which he mentors interested doctors in providing. An avid meditator, he has been a meditation instructor since 2004.
For the past several years Dr. Van Derveer has taught psychiatrists and other psychiatric providers integrative psychiatry in a number of settings, including course directing the CU psychiatry residents’ course as well as with Scott Shannon and Janet Settle at the Psychiatry MasterClass. In addition to his clinical work and teaching, he was co-investigator in 2016 a Phase II randomized clinical trial, sponsored by the Multidisciplinary Association for Psychedelic Studies (MAPS). He continues to support this protocol, now in a Phase III clinical trial under break-through designation by FDA.
Dr. Van Derveer is a diplomate of the American Board of Integrative and Holistic Medicine (ABoIHM) since 2013, and he was board certified in the first wave of diplomates of the new American Board of Integrative Medicine (ABIM) in 2016.
